Table 1 Baseline demographics and procedural characteristics.
IFN beta-1a N = 27 | Placebo N = 11 | p value | |
|---|---|---|---|
Demographics | |||
Age | 73.4 (SD, 9.6) | 73.9 (SD, 7.6) | 0.87 |
Sex (male) | 85% | 100% | 0.30 |
Hypertension | 16 (59%) | 5 (46%) | 0.49 |
Atrial fibrillation | 4 (15%) | 4 (36%) | 0.20 |
Coronary artery disease | 4 (15%) | 1 (9%) | 1.00 |
Hypercholesterolemia | 9 (33%) | 3 (27%) | 1.00 |
Diabetes | 5 (19%) | 2 (18%) | 1.00 |
COPD | 5 (19%) | 2 (18%) | 1.00 |
Asthma | 3 (11%) | 1 (9%) | 1.00 |
Major surgical features | |||
Duration of surgery (min) | 186 (SD, 76) | 169 (SD, 55) | 0.49 |
RBC substitution (mL) | 1573 (SD, 946) | 1378 (SD, 972) | 0.57 |
Platelet substitution (mL) | 357 (SD, 603) | 173 (SD, 212) | 0.18 |
Total volume substitution (mL) | 7159 (SD, 4133) | 6294 (SD, 1938) | 0.39 |
Left renal vein ligated | 3 (11%) | 0 (0%) | 0.54 |
Clamp above the renal arteries | 2 (7%) | 1 (9%) | 1.00 |
Open abdomen | 13 (48%) | 3 (27%) | 0.30 |
